USA – The FDA has placed a clinical hold on Denali Therapeutics’ Alzheimer’s drug before it even enters human trials. The decision has an impact on Takeda, which only recently…
Read MoreTakeda, Denali’s Alzheimer’s candidate drug hits regulatory drawback
